Join
Live feed
·
INSIDERFilingvia Quantisnow
Structure Therapeutics Inc. logo

Chief Development Officer Hall Ashley was granted 67,290 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GPCR (Structure Therapeutics Inc.) and more on Quantisnow.